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Abstract 
 
Methamphetamine  was  widely  used  in  the 
United States during the 1950’s and 60’s to 
treat  a  variety  of  conditions  before  its 
addictive  nature  and  harmful  side  effects 
were fully understood by the general public.  
The  government’s  ensuing  restrictions 
merely  forced  the  production  and  use  of 
methamphetamine  underground  as  the 
country  witnessed  an  explosion  of 
clandestine  production  and  distribution.  
Once viewed as the “poor man’s cocaine” 
used  exclusively  in  rural  areas, 
methamphetamine has spread to become an 
epidemic  that  now  transcends  class, 
geography, and race.  Much legislation has 
been passed over the years in response to 
the  growing  severity  of  the  problem,  as 
Congress has come to realize the enormity 
of  the  threat  that  this  drug  poses  to  its 
citizens and society at large.  This research 
paper  examines  the  history  of 
methamphetamine use, its prevalence in the 
U.S., its effects on the users, its imposition of 
societal costs, legislation in response to the 
growing problem, and additional measures 
that ought to be employed to help cure the 
nation of the ailments caused by this chronic 
illness. 
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Methamphetamine 
 
INTRODUCTION 
  Growing up in an upper-middle class neighborhood in the early 1990’s, Robert 
Lee
1 had a bright future ahead of him.  He had recently started junior high school at one 
of the nation’s top magnet schools, where he shared the same high hopes and ambitions 
as most children his age.  Unfortunately for Robert and so many others in similar 
situations around the country, all his plans became derailed the day one of his friends 
introduced him to methamphetamine.   
His use of methamphetamine initially started off casually as an activity with 
friends that helped to pass the time on lazy afternoons.  It quickly devolved into a strong 
addiction which soon occupied all of his time and consumed nearly all of his financial 
resources.  Within a blink of an eye, Robert found himself bouncing from school to 
school and unable to kick the habit no matter what he tried.  His pride would not let him 
enroll in a rehabilitation center no matter how much his friends and family implored him 
to do so.  Determined to deal with his problem on his own, he struggled for four long 
years to get himself clean and even managed to complete his high school education at an 
adult continuation school.  Although he did suffer some relapses from time to time, 
Robert had managed to get a hold of his addiction and was ready to move on with his life.  
He enrolled himself in a local college with the hope that his struggles with 
methamphetamine abuse and dealing with its related problems were behind him.    
The next few years of his life were plagued with medical visits to treat various 
ailments that refused to go away.  While Robert was no longer using methamphetamine, 
                                                 
1 Name has been changed.  
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it became clear to him that his years of abuse would exact a huge cost on his quality of 
life.  While the doctors were unable to say with absolute certainty that the 
methamphetamine use was the cause for his medical troubles, it seemed likely that the 
years of drug abuse had taken its toll on both Robert’s mind and body.  He soon learned, 
at the very young age of 26, that he was suffering from liver failure and would need 
dialysis.  Less than a year after this diagnosis, Robert lay in a comatose state in a hospital 
bed after suffering from multiple cardiac arrests.  On February 8, 2008, his parents were 
forced to make the most difficult decision of their lives as they decided to pull the plug 
on their eldest son. 
Robert’s story is not just that of another faceless person in middle-America.  
Robert was one of my closest friends, and his battle with methamphetamine was one that 
I was able to witness firsthand.  Robert’s personal struggles with methamphetamine 
brought the issue to light for me and made me realize that the methamphetamine 
epidemic had been the proverbial elephant in the room for much too long. 
This research paper takes a comprehensive look at the methamphetamine problem 
by reviewing the history of its use in the United States, its effects on the user, the 
associated harms it imposes on society, the federal legislation enacted in response to the 
problem, and additional measures that should be adopted to slow down the spread of this 
deadly drug. 
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WHAT IS METHAMPHETAMINE? 
BRIEF OVERVIEW 
  Methamphetamine is an illicit and highly addictive psychostimulant which is 
known to have its greatest effects on the central nervous system of the human body
2.  On 
the streets, it is commonly referred to simply as “meth”, “speed”, and “chalk”, while in 
its smokeable form, it is known as “crystal”, “glass”, “ice”, and “crank”
3.  It is a “white, 
odorless, bitter-tasting crystalline powder”
4 that can be used in a variety of ways 
including but not limited to injection, snorting, smoking, and ingestion, with the smoking 
and injection methods being preferable to users who are seeking a more intense and 
immediate “high”
5.   
  The immediate effects that a user experiences will depend on how the drug is 
taken, as those who either smoke or inject methamphetamine have reported to experience 
a very pleasurable and intense rush which lasts only a few minutes while those who either 
ingest or snort the drug have reported feelings of euphoria which are weaker but tend to 
last longer than the short and intense “flash” experienced by others
6.  Commonly 
observed psychological effects associated with methamphetamine abuse are agitation, 
paranoia, violent behavior, depression, psychosis, anxiety, and euphoria
7.   
In a desperate attempt to maintain their highs by taking more and more of the 
drug, meth users tend to go on binges when they use since the pleasurable effects of the 
                                                 
2 National Institute on Drug Abuse. National Institute on Drug Abuse Research Report Series: 
Methamphetamine Abuse and Addiction; September 2006, 1. 
3 Id. 
4 Id. 
5 Charles W. Meredith. Implications of Chromic Methamphetamine Use: A Literature Review, Harv Rev 
Psychiatry; May/June 2005, 143. 
6 Methamphetamine Abuse supra note 2 at 3. 
7 Timothy W. Lineberry & Michael Bostwick. Methamphetamine Abuse: A Perfect Storm of Complications, 
Mayo Clin. Proc; 2006, 77.  
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drug often wear off very quickly, even before the drug has left the system
8.  A common 
form of binging amongst users is known as a “run,” and it involves the user foregoing 
both sleep and food for days at a time while they are abusing the drug
9.  This is followed 
by a period of “tweaking”
10 which describes the period in which the user experiences a 
deadly combination of fatigue and restless irritability and anxiety
11.  Although continued 
use of methamphetamine will temporarily cure these symptoms, it also works to reinforce 
the user’s addiction, and after days of sleeplessness and further use, the user will typically 
“crash” into a state of unrestful sleep
12.   
BRIEF HISTORY 
  First derived from the stimulant amphetamine
13, methamphetamine was 
synthesized in 1893 by a Japanese pharmacologist Nagayoshi Nagai with the use of 
ephedrine.
14  It was not subject to widespread use until the 1940’s when it was 
implemented by both the Axis and Allied powers during the Second World War to help 
their respective military personnel both increase their performance and fight off fatigue, 
as well as by Japanese factory workers looking to increase their production output.
15  It is 
said that Japanese Kamikaze pilots were distributed high doses of methamphetamine 
before they took off on their missions.
16  Once World War II ended, the streets of Japan 
were overflooded with surplus stocks of methamphetamine from the military which 
                                                 
8 Methamphetamine Abuse supra  note 2 at 3. 
9 Id. 
10 BK Logan. Methamphetamine – Effects on Human Performance and Behavior, 14 Forens Sci Rev; 2002, 
133-151. 
11 Lineberry & Bostwick supra  note 7 at 77. 
12 Id. 
13 Definition of amphetamine 
14 Meredit supra  note 5 at 142. 
15 Id. 
16 David J. Jefferson. Meth: America’s Most Dangerous Drug, Newsweek; August 8, 2005. Available at 
http://www.msnbc.msn.com/id/8770112/site/newsweek/print/1/displaymode/1098/  
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resulted in the first full-blown epidemic of methamphetamine abuse with as high as 5% 
of the Japanese population estimated to have abused the drug and as high as 10% of those 
users having experienced related psychotic episodes.
17 
  In the United States, amphetamine was first used as a substitute for ephedrine in 
1927 and it soon became available in the 1930’s in the form of Benzedrine which could 
be found in over the counter (OTC) nasal inhalers and tablets that were available by 
prescription and was prescribed to treat numerous conditions
18.  The first report of 
amphetamine addiction was published in 1938 along with the first description of 
amphetamine psychosis in the same year
19.  Starting in 1951, federal law required 
prescriptions for products containing amphetamines
20 which were often prescribed as diet 
aids and to provide an extra boost for housewives across the nation
21.  By 1958, there 
were an estimated 3.5 billion tablets of legal amphetamine produced and in 1960, the first 
OTC methamphetamine inhaler hit the market but by 1965, they were taken off the 
counters with federal law requiring prescriptions for meth products
22.   
By the end of the 1960’s, methamphetamine use had become very widespread 
with 31 million prescriptions having been written in 1967 (mostly for women), an 
estimated 10 billion tablets of legal meth/amphetamine tablets having been produced, and 
a 1971 Chambers estimate that claimed 35,000 New York household residents used 
“speed” regularly compared to only 6,000 users of cocaine
23.   
                                                 
17 Meredith supra  note 5 at 142. 
18 Patricia Case. Harm Redux Conference – The History of Methamphetamine: An Epidemic in Context.  
August 19, 2005 
19 Id. 
20 Id.   
21 Jefferson supra  note 16. 
22 Case supra  note 18. 
23 Id.  
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In response to these changes along with the withdrawal of a few of the 
formulations of methamphetamine by various pharmaceutical companies in the U.S. 
market, California’s Bay Area saw the emergence of underground and clandestine 
methamphetamine home labs in the 1960’s
24.  These labs were quickly taken over by 
various biker gangs in California such as the Hell’s Angels and methamphetamine use 
spread wildly along the West Coast until efforts focused on these biker gangs by law 
enforcement began to shift control of the illicit meth market to dealers and traffickers 
based out in Mexico in the 1990’s
25. 
The problems arising from illicit production of methamphetamines took a turn for 
the worse once the Bay Area biker groups who had utilized a form of production known 
as the P2P
26 method of methamphetamine synthesis were forced to pursue other methods 
of production due to tighter federal regulation and stricter controls on P2P
27.  The new 
method of production that essentially replaced the P2P method is known as the 
ephedrine/pseudoephedrine reduction method (also known as the “Birch Method”) which 
relies on phosphorus-based precursors such as hypophosphoric acid or red phosphorus
28 
which produces a more highly potent form of methamphetamine
29.  This switch in 
production processes allowed for cheaper, simpler, and much more efficient production 
of meth, resulting in the emergence of “superlabs” which are capable of producing of 
more than ten pounds of methamphetamine in a single cycle,
30 as well as the emergence 
of do-it-yourselfers who are relying more on home production and less on the importation 
                                                 
24 MD Anglin, C Burke, B Perrochet, E Stamper, S. Dawud-Noursi. History of the Methamphetamine 
Problem, 32 J Psychoactive Drugs; 2000, 137-41 
25 Meredith supra  note 5 at 142. 
26 Method involving principal chemicals phenyl-2-propanone, aluminum, methylamine, and mercuric acid. 
27 Meredith supra  note 5 at 142. 
28 Id.   
29 Case supra  note 18. 
30 Meredith supra  note 5 at 142.  
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of such products
31.  The ease of production that resulted from this change of processes 
seems to have triggered the sudden spread of methamphetamine use across the nation.  
HOW WIDESPREAD IS THE METHAMPHETAMINE PROBLEM? 
  While the numbers may vary from source to source, the fact that 
methamphetamine use is widespread and a very serious problem is undeniable.  While it 
was once viewed as a “poor man’s cocaine” which was popular in mostly rural areas as 
well as the West Coast, it is a problem that transcends class, geography, and race as a 
quick glance at the users of meth in the U.S. reveals a wide spectrum of persons that runs 
the entire gamut from “soccer moms in Illinois, computer geeks in Silicon Valley, factory 
workers in Georgia, to gay professionals in New York”
32.   
  According to the 2006 results from the National Survey on Drug Use and Health, 
about 5.8% of the adult population (age 12 and older) had used methamphetamine at 
some point in their lifetime, with 0.77% of them having used it in the past year, and 0.3% 
of the adult population having used it in the past month.
33  This means that roughly 
700,000 citizens had illicitly used methamphetamine in the past month
34 alone, with 
roughly 1.8 million having used it in the past year and nearly 13.5 million Americans 
having used it during their lifetimes.  These latest figures tended to be significantly 
higher than reported in previous years because of changes to the methodology of the 
survey with respect to methamphetamine data, which were a result of the concern that 
some survey participants had previously failed to report their use of methamphetamine by 
                                                 
31 Case supra  note 18. 
32 Jefferson supra  note 16. 
33 Office of Applied Studies, Substance Abuse & Mental Health Serv. Admin. 2006 National Survey on 
Drug Use & Health; 2006.  Available at  
http://www.oas.samhsa.gov/NSDUH/2k6NSDUH/AppB.htm#B.4.6. 
34 Id. Available at http://www.oas.samhsa.gov/NSDUH/2k6NSDUH/2k6results.cfm#Ch2.  
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failing to recognize the drug when presented in the prescription drug context
35.  Although 
the recent increase may be attributable in part to the new methodology, the absolute 
numbers themselves are still very staggering and a cause for alarm.  It has been estimated 
that over 35 million people worldwide abuse methamphetamine or amphetamines in 
general, which pales in comparison to the estimated 15 million users of cocaine and less 
than 10 million users of various opiates internationally
36. 
  The 2007 data from in-school surveys by Monitoring the Future reveal that 1.8% 
of 8
th graders have used methamphetamine during their lifetime compared to 3.0% of 12
th 
graders
37 while 0.6% of 8
th graders had actually used methamphetamine in the prior 30 
days which is identical to the 0.6% of 12
th graders who had used in the past month
38.  
While these numbers have improved in comparison to past years, they are still much too 
high for a drug so dangerous.   
  Not only is the number of actual users a cause for concern but the meth-related 
health statistics and figures have also been rising in a startling fashion as well.  The Drug 
Abuse Warning Network, which is an agency that collects information showing drug-
related visits to hospital emergency departments across the nation, has data available 
which shows a 50% increase in methamphetamine-related visits to emergency 
departments from 1995 to 2002
39.   According to DAWN, methamphetamine visits were 
                                                 
35 Id. Available at http://www.oas.samhsa.gov/NSDUH/2k6NSDUH/AppB.htm#B.4.6. 
36 United Nations Office on Drug Control and Crime Prevention. World Drug Report 2000.  Available at 
http://www.unodc.org/unodc/en/world_drug_report_2000.html. 
37 LD Johnston, P.M. O’Malley, J.G. Bachman, & J.E. Schulenberg.  Monitoring the Future National 
Results on Adolescent Drug Use : Overview of Key Findings, (NIH Publication No. [yet to be assigned]) 
Bethesda, MD: National Institute on Drug Abuse;  2007. 
38 Id. 
39 Methamphetamine Abuse supra  note 2 at 3.  
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nearly 4% of all drug-related visits in 2004
40 as they totaled roughly 70,000 visits with 
2,391 of them being suicide attempts and 10,518 of the visitors seeking detox treatment
41. 
  Admissions for treatment for methamphetamine addiction have increased 
dramatically also as such treatment requests ballooned from roughly 21,000 in 1992, 
which represented slightly more than 1% of all treatment admissions, to over 150,000 
treatment admissions in 2004, which now nearly represented 8% of all drug-related 
treatment admissions
42.  This increase has been seen spreading across the country as well 
with only five states reporting treatment admissions rates higher than 24 per 100,000 of 
the population in 1992 and 21 states reporting such rates by 2002
43.  The National 
Institute on Drug Abuse has an early warning network that monitors drug abuse patterns 
in 21 major localities in the United States called the Community Epidemiology Work 
Group (CWEG)
44 and its June 2006 report revealed that methamphetamine use did not 
decrease in a single CWEG monitored area while it increased in nine CWEG areas, eight 
of which were already deemed to be high use areas (Atlanta, Denver, Honolulu, Los 
Angeles, Phoenix, San Diego, Seattle, and Texas)
45.  It was further reported by CWEG to 
be a growing problem in Saint Louis which saw a 15% increase in meth admissions and 
the drug itself was more generally available nationwide, despite a decrease in incidents 
and seizures
46.   
                                                 
40 Id. 
41 Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies. 
National Estimates of Drug-related Emergency Department Visits,. Drug Abuse Warning Network; 2004.  
Available at http://dawninfo.samhsa.gov/files/DAWN2k4ED.htm#Tab2. 
42 Methamphetamine Abuse supra  note 2 at 3. 
43 Id. 
44 Methamphetamine Abuse supra  note 2 at 2. 
45 National Institute on Drug Abuse. Epidemiolgic Trends in Drug Abuse: Advance Report, Community 
Epidemiology Work Group,; June 2006.  Available at 
http://www.drugabuse.gov/about/organization/cewg/Reports.html. 
46 Id.  
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All the available data and numbers bear out what most people have suspected for 
some time.  Methamphetamine abuse is a problem that affects too many U.S. citizens and 
there isn’t much data to suggest that the problem is getting any better. 
HOW DOES METHAMPHETAMINE AFFECT THE USER? 
EFFECTS ON THE CENTRAL NERVOUS SYSTEM 
  Methamphetamine is a stimulant drug that acts on the central nervous system by 
forcing the release of various monoamine neurotransmitters such as serotonin
47, 
epinephrine
48, and dopamine and unlike cocaine, which acts primarily by blocking 
transporters that are involved in the reuptake
49 of monoamines, methamphetamines 
employ a variety of primary mechanisms within the central nervous system which act in 
synergy as unusually potent releasers of monoamines
50.  For example, in addition to 
blocking the monoamine transporters as is known to occur with cocaine, 
methamphetamines also reverse transport of neurotransmitters through the transporters
51, 
thereby increasing the release of neurotransmitters.  Also, given its lipophilic nature, 
methamphetamine is able to accomplish increased central nervous system penetration 
which further contributes to and results in a higher level of potency than the related 
amphetamine compound
52. 
                                                 
47 Serotonin is a monoamine transmitter synthesized in serotonergic neurons in the central nervous system 
which is believed to play an important role in the modulation of anger, aggression, body temperature, mood, 
sleep, sexuality, and appetite as well as stimulate vomiting.  
48 Epinephrine is a transmitter classified as a catecholamine, a monoamine derived from the amino acids of 
phenylalanine and tyrosine, which plays a central role in the short-term stress reaction commonly referred 
to as “fight or flight”  
49 Blocking reuptake forces the neurotransmitters to remain in the synaptic gap for a longer period, thus 
resulting in increased stimulation. 
50 Alasdair M. Barr. The need for speed: an update on methamphetamine addiction, 31 J Psyciatry Neurosci 
5; 2006, 302.   
51 Id.   
52 Meredith supra  note 5 at 143.    
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  It is believed that most of the benefits and pleasurable aspects of 
methamphetamine use are a result of aforementioned processes causing releases of very 
high levels of dopamine and related monoamines
53.  Dopamine is the neurotransmitter 
that is responsible for a host of feelings including pleasure and motivation, but it seems as 
though this unusually high release of dopamine is the root cause behind 
methamphetamine’s degenerative effects on the nerve terminals in our brains
54.   
  The acute effects that accompany the release of neurotransmitters in our central 
nervous system are feelings of alertness, well-being, and euphoria along with decreased 
appetite and in some cases, increased libido
55.  In addition to the feelings of happiness, 
users also desire the effects of higher levels of energy and curiosity, increased levels of 
interest in external stimuli, as well as an initial onset of decreased anxiety
56.  Various side 
effects are often experienced by the users, resulting from the effects of the 
methamphetamine on both norepinephrine and epinephrine release by the adrenal glands, 
which include but are not limited to “increased blood pressure, hyperthermia, stroke, 
cardiac arrhythmia, stomach cramps and muscle tremor; acute negative psychological 
side effects include anxiety, insomnia, aggression, paranoia, and hallucinations
57. 
  Repeated use of the drug results in depletion of neurotransmitter resources 
accompanied by withdrawal symptoms which tend to be psychiatric, as opposed to 
physical complaints, and manifests as depression, anxiety, irritability, fatigue, intense 
cravings for the drug, and oftentimes, even aggression and paranoia
58.  The intensity of 
                                                 
53 Methamphetamine Abuse supra  note 2. 
54 Id. 
55 Barr supra  note 50. 
56 Meredeith supra  note 5 at 143. 
57 Id. 
58 Id.  
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this withdrawal period can even lead users to thoughts of suicide as the accompanying 
depression is much more extreme than that found in cocaine users and can even last up to 
a period of 12 months
59 
LONG TERM EFFECTS ON THE USER FROM CHRONIC USE  
ADDICTION 
  One of the most commonly seen long-term effects on the users of 
methamphetamine is the resulting addiction to the drug, which is a “chronic relapsing 
disease, characterized by compulsive drug seeking and use, accompanied by functional 
and molecular changes in the brain”
60  Methamphetamine abuse is an incredibly difficult 
habit to break due to its effects on the central nervous system and the accompanying 
withdrawal symptoms, which often results in this addiction.  Further contributing to the 
addiction and chronic abuse is the tolerance that users develop to methamphetamine’s 
pleasurable effects, which cause the abusers to take higher doses or increase either the 
frequency or method of intake in an effort to intensify the desired effects
61 
PATHOPHYSIOLOGICAL EFFECTS 
  Continued administration of methamphetamine in animals has been shown to 
result in cerebrovascular changes as well as signs of hemmorage and case studies have 
further strengthened these findings, as they have linked death in human abusers of 
methamphetamines to increased frequencies of pulmonary edema, cerebral hemorrhage 
and congestive heart failure
62. 
“A FOREST FIRE OF BRAIN DAMAGE” 
                                                 
59 Id. 
60 Methamphetamine Abuse supra  note 2 at 5.   
61 Methamphetamine Abuse supra  note 2. 
62 Meredith supra  note 5 at 144-5.  
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  A high resolution M.R.I. image of a long-time methamphetamine addict’s brain 
showed “a forest fire of brain damage” that was even beyond the expectations of Dr. Paul 
Thompson, an expert on brain mapping from the University of California, Los Angeles
63.  
The limbic region of the brain which is responsible for drug craving, mood, emotion and 
reward was missing 11% of its tissue that was just “dead and gone” while the 
hippocampus, which is responsible for creating new memories in the brain had lost 8% of 
its tissue which was comparable to the effects of early onset Alzehimer’s on the brain
64.  
In another shocking development, the study showed that the white matter of the brain 
which is largely composed of various nerve fibers that connect different parts of the brain 
was severely inflamed causing the size of the addicts’ brains to be 10% larger than 
normal
65.  Given the amount of damage to the hippocampus, it came as no surprise that, 
the addicts in this study fared significantly worse than healthy participants of the same 
age in memory tests
66. 
COGNITIVE EFFECTS 
  Numerous studies have confirmed that methamphetamine abuse can contribute to 
cognitive impairment as consistent exposure over time can result in very serious 
neuropsychological deficits
67  Various studies and tests have been performed to track the 
cognitive effects of long-term meth use on its abusers and the findings have all pointed 
towards various levels of impairment.  The severity of these impairments is directly 
correlated to both frequency of use by the user and the severity of dependence on the 
                                                 
63 Sandra Blakeslee.  This is Your Brain on Meth: A ‘Forest Fire’ of Damage, NY Times.  July 20, 2004.  
Available at http://amphetamines.com/braindamage.html. 
64 Id. 
65 Id. 
66 Id. 
67 Barr supra  note 50 at 306.  
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drug
68.  Meth users have been shown to display working memory deficits in tasks 
involving immediate recall components on an auditory verbal learning test as well as 
requiring 18-30% more time to complete working memory components of a California 
assessment test
69  Also consistent with the propensity of users of methamphetamine to 
become distracted, attention deficits were observed in some cognitive tests, with one of 
the studies showing evidence of impairments in executive function in meth users, 
including impairment to abstract reasoning, planning, and behavioral flexibility abilities
70.  
The aforementioned deficits tend to mirror the cognitive impairment that is found in 
people who suffer from attention-deficit hyperactivity disorder (ADHD). 
  What is unique to the cognitive deficits found in methamphetamine users is that 
there are of a different type than those suffered by users of other stimulants
71.  While both 
abusers of cocaine and meth suffer significantly from impaired verbal memory, 
methamphetamine abusers also suffer greatly from impaired performance on perceptual 
speed and information manipulation, especially when these tasks are combined with 
visuomotor scanning
72.  What is even more troubling is the fact that impairment lasts well 
into abstinence and actually worsens during the initial phases of abstinence, as many 
users are found to perform considerably worse on the various memory tasks, months into 
their recovery
73.     
 
 
                                                 
68 Meredith supra  note 5. 
69 Barr supra  note 50 at 306. 
70 Id. 
71 Meredith supra  note 5 at 146. 
72 Id.  
73 Id.  
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METH-INDUCED PSYCHOSIS 
While impairment to memory and reasoning are all serious concerns with respect 
to the long-term effects of meth abuse to the user, the most prominent cognitive effect 
that is related methamphetamine use is the development of a drug-related psychosis in its 
users
74.   
  Methamphetamine users are at a higher risk to suffer from psychosis for two 
reasons.  By using meth, they not only risk being subject to an episode of meth-induced 
psychosis, but are also more likely to suffer from additional psychotic disorders such as 
schizophrenia
75.  Studies have shown that methamphetamine use can exacerbate and 
precipitate the symptoms that are common in those who suffer from schizophrenia
76 and 
as a result, the drug users who are more prone to psychosis due to pre-existing conditions 
are at a significantly higher risk of exhibiting psychotic symptoms
77. 
  The symptoms associated with methamphetamine-induced psychosis are 
hypersensitivity to the environment, persecutory delusions, and both visual and auditory 
hallucinations, and these symptoms normally last only a few hours with extreme cases 
lasting up to a week since withdrawal of the drug, although symptomatic episodes lasting 
even longer have been observed in some people
78.  Methamphetamine psychosis is 
believed to be the result of excess synaptic dopamine which would result in symptoms 
similar to those found in patients who suffer from schizophrenia.  There a host of factors 
that could potentially increase one’s chances of suffering from methamphetamine 
                                                 
74 Barr supra  note 50 at 306. 
75 Rebecca McKetin.  The Prevalence of Psychotic Symptoms Among Methamphetamine Users, Research 
Report,  101 Addiction 10; October 2006, 1473. 
76 C Curran, N Byrappa, A McBride. Stimulant Psychosis: Systematic Review, 185 Br J Psychiatry; 2004, 
196. 
77 CK Chen, SK Lin, PC Sham, D Ball, EW Loh, CC Hsaio, et al.  Pre-morbid Characteristics and Co-
morbitidy of Methamphetamine Users With and Without Psychosis, 33 Psychol Med; 2003, 1407. 
78 McKetin supra note at 75.  
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psychosis, such as using larger than normal amounts of the drug, first use of the drug at 
very young ages, along with a genetic predisposition to schizoid characteristics
79.  Higher 
rates of other psychiatric disorders such as alcoholism, depression, and anti-social 
personalities were also seen in people who suffer from meth-induced psychosis than users 
without the psychosis
80.   
  Other neurological problems such as learning disabilities, birth trauma, and 
traumatic brain injuries can all increase the risk of the user suffering from treatment-
resistant meth-induced psychosis
81.   Unfortunately for those who have suffered from 
methamphetamine psychosis in the past, it seems that it is likely to recur, even in patients 
that are currently abstaining from any methamphetamine use and who are experiencing 
remission of psychotic symptoms
82.  The fact that meth users are not only at risk for 
experiencing a psychotic episode at the time of use but also at later points in their lifetime, 
only serves to complicate the issue. 
  Studies conducted in Japan, an area known to have a high percentage of meth 
users, have shown that anywhere from 36% to 64% of methamphetamine users who 
previously experienced psychotic symptoms continued to experience them for more than 
ten days since the last date of use, even though the drug is flushed out of the system 
within five days
83.  Another study that surveyed female inmate methamphetamine users 
observed that nearly 21% of those who had previously experienced psychotic symptoms 
had remained in such a state for more than six months and nearly half had experienced 
                                                 
79 Chen supra  note at 77. 
80 Id. 
81 D Fujii. Risk Factors for Treatment-resistive Methamphetamine Psychosis,14 J Neuropsychiatry Clin 
Neurosci; 2002, 239. 
82 K Yui, T Ishiguro, K Goto, S Ikemoto,Y Kamata.  Spontaneous Recurrence of Methamphetamine 
Psychosis: Increased Sensitivity to Stress Associated with Noradrenergic Hyperactivity and Dopaminergic 
Change, 249 Eur Arch Psychiatry Clin Neurosci; 1999, 103. 
83 Barr supra  note 50 at 306.  
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“flashbacks”
84 during their 15-20 month prison terms, even after returning to their pre-
morbid states
85.  The studies from Japan further indicate that those who have suffered 
from a meth-induced psychosis are likely to suffer from psychotic relapses in future high-
stress situations (even after years since cessation of use), and these users also tend to 
become more and more vulnerable to environmental stress
86. 
  It seems evident from the studies and research that a relationship between 
methamphetamine use and psychotic episode occurrences exists but how often does it 
occur?  A study conducted in Australia set out to examine the prevalence of psychotic 
symptoms among meth users by recruiting participants through advertisements in 
magazines, flyer, and word of mouth, and they were able to take observe 309 participants 
who were over 16 years of age and had taken the drug at least on a monthly basis for the 
past year
87.  The study was conducted as a face-to-face interview questionnaire which 
involved measuring the level of drug use, recording the demographics and pre-morbid 
mental health, and screening for psychosis amongst the participants
88.  The majority of 
the participants were weekly users of methamphetamine in the past year and over half 
admitted to being dependent on the drug, and of these participants, 5% admitted to having 
been diagnosed with schizophrenia, another 5% admitted to having been diagnosed with 
another psychiatric disorder such as a mania or bipolar disorder, and 7% reported to 
having previously been diagnosed with drug-induced psychosis
89.  Some sort of 
relationship between schizophrenia and meth abuse seems to be evident as the National 
                                                 
84 Flashbacks are spontaneous recurrences of psychotic symptoms that would fit criteria for a paranoid-
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Institute of Mental Health estimates that roughly 1.1%
90 of the adult population is 
diagnosed with schizophrenia while the studies show a marked increase in that nearly 5% 
of the meth sample population was diagnosed with the disorder. 
  This study found that 13% of the methamphetamine users had screened positively 
for psychosis and that nearly 23% of the users had experienced unusual thoughts, 
hallucinations and suspiciousness, and even after controlling for participants with a 
history of schizophrenia and other psychiatric disorders, the prevalence of clinically 
significant symptoms remained extremely high at 18%
91.  Those users who admitted to 
being dependent users were three times as more likely to experience clinical symptoms 
than their non-dependent counterparts and a whopping 27% of dependent users were 
subject to psychotic episodes, even after excluding those who had a history of mental 
illness
92.  Depending on your point of view, the fact that only 13% of methamphetamine 
users had screened positively for psychosis in the past year may not be that impressive, 
but given the high number of estimated methamphetamine abusers in this country, this 
problem should raise a red flag as a great number of people may be affected by this 
drastic deterioration of their mental health.  No matter how you look at it, “the prevalence 
of psychosis among methamphetamine users was found to be alarmingly high in 
comparison with the general population”
93 and it is just another serious health risk that 
methamphetamine abusers must consider. 
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METH USERS ARE HURTING THEMSELVES, WHY SHOULD WE CARE? 
  Methamphetamine abuse is unique when compared to many other illicit drugs in 
that there a greater number of negative externalities involved as it relates to the actions 
and behaviors of those who use and produce the drug.  If methamphetamine abuse only 
affected those who decided to use it, the laissez faire attitude exhibited by many when it 
comes to its use and regulation would be acceptable, and I feel as though I would be able 
to make better sense of what seems to be a general lack of public awareness about the 
severity of the methamphetamine problem.  Unfortunately, widespread methamphetamine 
use is a problem that not only affects its users but is a crisis that has the potential to affect 
the entire community.  Methamphetamine use and production is capable of posing 
numerous environmental, health, criminal, and social problems that put a great number of 
innocent citizens at risk. 
PRODUCTION 
  The process of producing of methamphetamine is such that in the past, a person 
with a rudimentary understanding of chemistry and access to common ingredients found 
in household cleaners and cold medications was able to produce it in their own home, 
which makes it very different from other illicit drugs such as cocaine and opiates which 
have to be grown.  This ease of production contributes to the problem in various ways. 
HOW TO COOK METHAMPHETAMINE 
  An article published in the Journal of Drug Issues that surveyed the home 
production of methamphetamine by users in rural Kentucky and Arkansas revealed just  
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how easy it is for anybody with access to these basic ingredients to set up a home 
laboratory for production of methamphetamines
94.   
  All of the participants in the study reported to use the Birch Reduction process 
which refers to a scientist named Arthur Birch who first developed the concept of a 
synthetic chemical reduction
95.  The main ingredients for the Birch method are anhydrous 
ammonia, lithium metal, and ephedrine/pseudoephedrine, while secondary ingredients 
may include camping stove fuel, denatured alcohol, table salt, and drain cleaner, which 
can all be found at local merchandisers
96. 
  Lithium metal is easily procured by the large-scale purchases of lithium batteries, 
while obtaining the anhydrous ammonia (a liquefied gas used as an industrial refrigerant) 
poses some difficulty as possession is restricted to authorized persons, such as farmers
97.  
According to the participants, anhydrous ammonia is still readily available through either 
illegal purchase from farmers, theft, and via homemade substitutes, which can be 
produced in as little as 20 minutes
98.  While both state and federal legislation regulate and 
monitor the sales of both ephedrine/pseudoephedrine, home cookers often employ 
multiple purchasers (usually users who are paid back with drugs) who simply cross 
nearby state lines in order to purchase the desired amounts
99. 
  Once the ingredients have been gathered, the actual reduction process is very 
simple as described by the participants.  One popular recipe begins with grinding the 
ephedrine/pseudoephedrine pills down to a powder base, mixing it with a gallon of 
                                                 
94 Rocky L. Sexton, Robert G. Carlson, Carl G. Leukefeld, & Brenda M. Booth.  Patterns of Illicit 
Methamphetamine Production (“Cooking”) and Associated Risks in the Rural South: An Ethnographic  
Exploration, Journal of  Drug Issues; 2006, 853-876. 
95 Id. at 863.   
96 Id. at 859. 
97 Id. at 859-960. 
98 Id. at 860. 
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denatured alcohol, and then letting it sit for 24 hours before straining it through filters to 
remove the pill coating
100.  The resulting powder is quickly cooked down to a white 
powder base on an electric skillet before being mixed in a five quart cooler with the 
ammonia, lithium strips, and some stove fuel
101.  The cooler is taped up and shaken, 
before being allowed to sit for another 24 hours and after the 24 hours has passed, the 
liquid in the cooler is simply strained through a large funnel filter which will catch the 
methamphetamine, which now needs only to be dried
102.  This ease of production is a 
very big reason why methamphetamine use has become so popular, and it is also the 
reason for the remarkably high number of clandestine home laboratories. 
HOME LAB v. “SUPERLAB” 
  Home methamphetamine laboratories are classified as those run by “users” and 
typically cannot create more than 280 doses at a single time and production from these 
labs is estimated to produce only 20% of the total supply of the supply
103.  The ease of 
production causes many of these home labs to spring up as evidenced by the fact that 
roughly 8,000 of the 8,300 meth labs that were seized in 2001 were of the home-user 
variety
104.  However, due to the necessary size restrictions that accompany these make-
shift home operations, which are often even located in areas as small as the beds of pick-
up trucks (a mobile home lab), they only account for a small portion of the total 
methamphetamine output.  These home labs are often characterized as primitive and have 
been referred to as a “jumble of over-the-counter pseudoephedrine, household lye, and 
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scraped-away matchbook covers”
105  These labs can be found in a variety of 
environments ranging from urban centers, to suburbs, and to rural farms, as the make-
shift laboratory set ups have been found in rental properties, apartments, hotels, self-
storage units, barns, auto repair shops, briefcases, national forests
106, and even inside 
caves and abandoned mines
107. 
  “Superlabs”, on the otherhand, have reached “a level of sophistication, uniformity, 
and efficiency seldom seen”
108 in home-user labs.  These labs are in the business of mass 
production as their operators are not engaged in this activity for personal use but rather 
large profits
109.  By implementing the use of commercial-grade lab equipment in 
conjunction with enormous amounts of chemicals, these superlabs are capable of 
producing up to one million doses of methamphetamine in a single run
110.  The signature 
piece of equipment in the superlabs is a device originally designed for scientific research 
which is referred to as a “22” due to the fact that it is a 22-liter reaction vessel.
111  These 
globe-shaped pieces of glassware brew the mixture of pseudoephedrine, red phosphorus, 
and hydriodic acid while the attached orange hoses lead to kitty litter filled boxes which 
serve the purpose of absorbing the reaction gases.  One superlab that was discovered had 
used twelve “22”s strung together and was able to produce over 144 lbs of pure meth per 
batch.  Some home cookers have estimated that they could earn profits to upwards of 
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$2500 for each ounce of methamphetamine
112 that they produce, so the profits that these 
superlabs are earning are staggering to say the least. 
  Methamphetamine laboratory seizures reached an all-time high in 2003 with over 
10,000 of such facilities being seized and had dropped dramatically to roughly 4,000 by 
2006
113.  Although the drastic drop in the number of meth lab seizures should be viewed 
as a positive sign, it should be noted that every single meth laboratory that is up and 
running in this country poses very serious health risks to the surrounding environment 
and the community at large. 
METH LAB EXPLOSIONS AND FIRES 
  Roughly 15% of all underground meth labs are discovered by law enforcement as 
the result of a fire or explosion caused by the careless use of very volatile and hazardous 
chemicals and unsafe manufacturing practices employed by the home cookers
114.  
Oftentimes, chemicals that are not properly labeled and incompatible with each other are 
stored together thereby increasing the chances of a big explosion or fire when also in the 
presence of other highly combustible materials left near stovetops and other heating 
devices
115.  Hydrogenerators which are often used in illegal meth production have been 
referred to as bombs waiting for ignition
116.  The dangerous volatility of the chemicals 
compounded with the facts that the cooks are usually not well-versed in chemistry and 
may be operating under the influence of the drug during production, all add to the 
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likelihood of such explosions taking place
117.  Obviously, these fires and explosions do 
not only risk the health and well-being of the methamphetamine cookers themselves, but 
of any neighbors and other innocent passerbys who are within the general vicinity when 
such fires and explosions occur. 
ENVIRONMENTAL EFFECTS 
  Clandestine meth production sites are often found to house hazardous materials 
that are flammable, toxic, and explosive and due to their classification as hazardous 
wastes, they must be managed and disposed of with great care upon discovery
118.  
Cooking even very small amounts of methamphetamine can result in large amounts of 
hazardous byproducts
119 as it is often estimated that nearly six pounds of toxic residue 
result from each pound of meth production
120.  These byproducts are frequently disposed 
of improperly in various indoor/outdoor drains, on the ground, and into neighboring 
bodies of water thereby contaminating the soil, water, and air,
121 and escaping vapors 
have been known to seep into both wood and plaster while much of the liquid residue can 
be found in sinks and bathtubs after dumping.
122  The environmental hazard that is of 
primary concern from these activities is the contamination of groundwater with volatile 
organic compounds
123.  Not only are humans affected by these sites but there is evidence 
that these activities have grave consequences for the flora and fauna in the neighboring 
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environment.  In Apache County, Arizona, environmental contamination from these meth 
labs has resulted in the deaths of 150 year old ponderosa pines, the conversion of nearby 
ravines to toxic waste dumps, the removal of tons of contaminated soil, and the death of 
numerous cattle downstream from the site, among other atrocities
124.  Environmental 
cleanup costs related to meth labs are a very legitimate concern as they can be as low as 
$2500
125 on average but as high as $150,000 in extreme cases
126. 
METH LAB CONTAMINATION 
  In addition to the fires and explosions that may happen due to the chemical 
substances involved in meth production, other forms of contamination may occur from 
chemical spills and from various substances and vapors that are being released during the 
cooking process
127.  The likelihood that these dangerous chemicals will contaminate the 
areas used for meth production is incredibly high and it is certain that such contamination 
will be found all over from the furniture, to the clothing and even inside of the walls for a 
period of time lasting potentially for years
128.  People who are present near the production 
process may inhale these toxic substances, be accidentally pricked by needles, absorb 
methamphetamine or related toxic substances via skin contact with contaminated sources 
and directly ingest chemical ingredients or byproducts
129.  
Exposure to low levels of these chemicals may cause a variety of symptoms 
ranging from symptoms as mild as nausea and fatigue to far more serious situations such 
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as loss of consciousness and even death while chronic exposure to this type of chemical 
contamination has been linked to cancer, brain damage, and complications in 
pregnancy
130.    Acute injuries resulting from a massive chemical exposure generally pose 
a much higher health risk than the risk of complications related to chronic toxicity and 
cancer
131.  The Hazardous Substances Emergency Events Surveillance system which 
records acute hazardous substance-release events claims that 4% of the 40,349 events 
recorded from early 2000 to mid 2004 were associated with meth labs and that roughly 
31% of these occurrences resulted in injuries, which is a higher percentage than found in 
non-meth-related substance release incidents
132.  These contamination risks do not only 
affect the users, but also their friends, neighbors, families, any law enforcement personnel 
who may report to the scene
133, firefighters, environmental clean-up crews, and even 
future residents
134.  As devastating as these effects are for those exposed to these risks, 
the fact that so many children are unwittingly affected simply exacerbates the problem 
tenfold. 
CHILDREN AND METH 
  Children who are victims to the harms associated with methamphetamine 
production are special not only because they are unintended victims but due to the 
physiological differences
135 between themselves and adults and their inability to take 
measures to protect or defend against the ensuing harms.  Since the brains and bodies of 
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young children are still developing, any type of exposure to the aforementioned 
chemicals and byproducts is far riskier, as they are incapable of eliminating the chemicals 
from their systems as efficiently as adults
136.  This coupled with the fact that they are far 
more likely to crawl around on contaminated substances and put contaminated objects in 
their mouth while exploring their homes, makes the danger to children enormous
137. 
  Not only are these children at a higher risk for exposure to dangerous chemicals, 
they are also often the victims of serious abuse and neglect from their negligent 
caretakers
138.  Children who grow up in these environments are more likely to be both 
physically and sexually abused by members of the family or others who are often present 
at the production site, and at the same time, they are also likely to be neglected by their 
own parents whose use of the drug has caused them to become careless, thus causing 
them to lose the ability to nurture their loved ones
139.  The effects from such physical and 
sexual abuse are only heightened by the accompanying emotional trauma that these 
children experience from witnessing such behavior
140.  These same children often lack 
basic food and medical care, not to mention the watchful eye of a single responsible adult 
to supervise their daily activities
141.   
  The physical abuse that is inflicted on these children is not only limited to acts of 
violence from the parents, but often results from the booby traps that are accidentally set 
off by the children
142.  These traps are set up in these meth sites to ward off unwanted 
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visitors and law enforcement officials
143 but often end up hurting unsuspecting people as 
well.  The abuse that these children must deal with extends to emotional maltreatment 
that is oftentimes much more harmful than any physical punishment that they must 
endure.  They are often taught to lie to authorities regarding their parents’ behavior, 
ordered to steal ingredients for the manufacture of the drug, forced to participate in the 
cooking process, and left to witness the generally disturbing and shocking behavior of 
their parents
144.  It should come as no surprise that they often exhibit emotional and 
behavioral problems such as low self-esteem, poor social skills, and in extreme cases, an 
attachment disorder which makes it difficult for these kids to form relationship and build 
trust, at later stages in their lives
145. 
METHAMPHETAMINE AND THE UNBORN 
  Not only does methamphetamine abuse harm the children who are present but it 
also poses great risks on the unborn fetus as meth use causes increases in both blood 
pressure and heart rate to expecting mothers which may lead to premature births or 
spontaneous abortions
146.  Drug use also affects the placenta of the mother, which 
provides oxygen and nutrients to the baby and if the drug itself is passed to the baby 
through the placenta, it can potentially cause a myriad of health issues for the baby such 
as prenatal stroke or heart damage
147. 
  Even if the babies are able to make it to term, they often exhibit additional health 
issues as up to 4% of the newborn infants who were exposed to methamphetamine in 
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utero were born with withdrawal symptoms
148.  These babies were often very sleepy for 
the first few weeks, but soon turn jittery and exhibit poor sleeping and feeding patterns as 
well as a poor ability to self-regulate in stressful situations
149.  Even if they manage not to 
show any noticeable behavioral signs at birth, they are still at a higher risk for contracting 
various diseases such as hepatitis and HIV
150. 
METH AND HIV 
  Meth use is also a contributor to the spread of HIV in this country because its use 
often leads to its users engaging in risky, unprotected sex and also sharing contaminated 
needles during use.  Methamphetamine use often causes the sexual behavior and desires 
of its users to become altered as the drug lowers their inhibitions and has even been 
shown to increase the likelihood of homosexual behavior from those who have only 
engaged in heterosexual behavior in the past
151.  Not only are those engaging in riskier 
sexual behavior subject to an increased risk in the spread of HIV but those engaging in 
traditionally safe sexual practices are at risk as well .  A physical side effect that is often 
seen in meth users is a noticeable shrinkage in the size of a man’s penis when it is erect 
which will often lead to condoms slipping off during intercourse, and for those engaging 
in homosexual sex, the drug can lead to the drying of mucous in various membranes 
which will result in sex that is “dryer” than usual
152 thus resulting in unexpected tears in 
the condom.  Apart from the riskier sex practices that are commonly observed, users also 
increase the chances of contracting HIV by sharing intravenous needles.  These increased 
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risks are compounded with the fact that meth users are more likely to be selecting sexual 
partners from a pool exhibiting a higher prevalence of HIV than the rest of society
153.  
The spread of HIV and its associated costs is just another problem that society as a whole 
must deal with in regard to this widespread epidemic. 
METH USERS AND VIOLENCE 
  While it has long been suspected that a correlation exists between illicit drug use 
and acts of violence by its users, a recent study performed to track the relationship 
between methamphetamine abuse and acts of violence seemed to confirm this hypothesis.  
The study involved 106 respondents between the ages of 18-25 who had used 
methamphetamine for a minimum of three months and all resided in Los Angeles County.  
34.9% of the respondents admitted to committing an act of violence while under the 
influence of methamphetamine with 61.1% of those violent acts involving domestic 
relationship and nearly 10% of those acts involving random acts of violence to 
strangers
154.  The most alarming discovery, in my opinion, was that 45.9% of those who 
had engaged in some type of violent behavior reported that they had never committed a 
violent act prior to the incident brought on by the methamphetamine abuse
155.  This study 
tends to show is that methamphetamine is a risk factor for violence as every subject of the 
study agreed that methamphetamine had clear violence potential as nearly all of them 
knew at least a single person who had gone “too far” while under its influence, even if the 
subject himself, had not
156.  While all of these numbers and findings should be viewed in 
the proper social and environmental context, the numbers do seem to suggest at the very 
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least, that there is likely to be some causal link between meth use and violent acts.  This 
type of violent behavior from meth users affect not only themselves, but the unfortunate 
people who end up being the victims and the object of their violent aggressions. 
METH USE AND IDENTITY THEFT 
  Violent acts are not the only crimes that are being committed by meth users as a 
recent intelligence bulletin from the National Drug Intelligence Center revealed that both 
users and distributors are more frequently participating in the crime of identity theft in 
order to both acquire the funds for drug purchases and to fund their illicit drug trafficking 
operations
157.  The abusers often generate quick cash by stealing personal checks or by 
using stolen credit card information to purchase items which they later sell or use in trade 
for more of the product
158.  Oftentimes, stolen identity information is the good itself that 
is being offered in a trade for methamphetamine, which the distributors then take and 
trade to the producers of the drug.   These stolen identities are not only used to fund their 
operations but they also serve as a useful tool in laundering their drug proceeds as it 
allows them to set up bank accounts to transfer funds and even apply for mortgages when 
acquiring property
159.  These criminals have even used these stolen identities to supply to 
members of their own organization in order to help them better evade law enforcement or 
possibly avoid deportation.  There is the growing fear that soon enough, meth users may 
even begin to use stolen identities when seeking medical treatment in order to avoid 
detection by law enforcement, which could lead to serious complications such as the 
medical records of these victims being changed and misdiagnoses and mistreatments 
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resulting from such changes
160.  It is now quite evident that the social costs imposed on 
society by those involved in either the use or production of methamphetamine are 
enormous and that something must be done to address the spread of this plague. 
WHAT IS THE GOVERNMENT DOING? 
FEDERAL LEGISLATION AFFECTING METHAMPHETAMINE 
CONTROLLED SUBSTANCES ACT OF 1970 
  The Controlled Substances of 1970
161 set the federal foundation for regulation of 
methamphetamine as it was Congress’ first comprehensive consolidation of legislation to 
control the use of illicit substances in the United States.  Taking a look at the structure 
and provisions of the CSA will provide insight into overall scheme for regulation of 
methamphetamine and the basic controls that have been put in place to control for its use, 
manufacture, and distribution in the United States.  When passing the Controlled 
Substances Act, Congress acknowledged that many of the drugs that would be regulated 
could have very useful and legitimate medical purposes that were necessary for the 
welfare of the American people, but that the uncontrolled importation, manufacture
162, 
and use of these substances could have a deleterious effect not only on the public health 
but on interstate commerce as well
163. 
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  The Act gave the Attorney General the power to add the regulated substances into 
one of five schedules
164 or to transfer the substances between the schedules if it found 
that the substance had a potential for abuse
165.  While decisions to list a substance would 
be made by the Attorney General on the record following an opportunity for a hearing, 
any decisions to either add or remove a substance from a schedule would also depend on 
the specific requirements listed for each schedule under Section 812
166.  The Attorney 
General was required to look at a host of factors when making the determination whether 
or not to control or remove specific substances from the schedules: actual or relative 
potential for abuse, scientific evidence of pharmacological effects, current scientific 
knowledge regarding the substance, history and current patterns of abuse, scope and 
duration of abuse, risks to public health, psychic and physiological dependences, and 
whether the substance in question was already an immediate precursor
167 for a previously 
controlled substance
168.  
  With respect to the aforementioned immediate precursors, the Attorney General 
was allowed to place an immediate precursor into the same schedule as the substance for 
which it was an immediate precursor or any other less stringent schedule, but this did not 
mean that any and all substances that were precursors to the immediate precursor would 
necessarily be listed on one of the schedules as a controlled substance
169. 
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  The Controlled Substances Act established five separate schedules of 
classification for the controlled substances, each with their own characteristics and 
requirements that needed to be satisfied in order for the regulated substances to qualify 
for listing
170.  For example, drugs that are listed as Schedule I drugs (the most dangerous) 
would have to exhibit a high potential for abuse, have no currently accepted medical use 
in treatment in the U.S., and also exhibit a lack of accepted safety for use under medical 
supervision
171.  Schedule II drugs, which are generally thought to be less dangerous than 
those listed under Schedule I must exhibit a high potential for abuse, have a currently 
accepted medical use in treatment in the U.S. subject to severe restrictions, and also 
exhibit tendencies to lead to severe psychological or physical dependence
172.  
Methamphetamine, its salts, its isomers, and the salts of its isomers are currently listed as 
Schedule II controlled substances
173 because it has shown the requisite high potential for 
abuse and dependence among its users but is also currently used in some forms of 
medical treatment, albeit subject to very severe restrictions
174.  Accordingly, all the 
restrictions and regulations that are discussed here on apply directly to 
methamphetamines. 
  In addition to giving the Attorney General the power to designate drugs as 
controlled substances, the Controlled Substances Act also authorized the Attorney 
General to regulate the “registration and control of the manufacture, distribution
175, and 
                                                 
170 21 U.S.C. 812. 
171 21 U.S.C. 812(b)(1). 
172 21 U.S.C. 812(b)(2). 
173 21 C.F.R. § 1308.12 Schedule II (d)(2). 
174 Desoxyn (methamphetamine tablets) is currently available as a Schedule II prescription drug and has 
been approved by the FDA to treat Attention Deficit Disorder with Hyperactivity and Exogenous Obesity.  
Available at http://www.fda.gov/medwatch/SAFETY/2006/Apr_PIs/Desoxyn_PI.pdf 
175 The term ''distribute'' means to deliver (other than by administering or dispensing) a controlled substance 
or a listed chemical.  21 U.S.C. 802(11).  
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dispensing of controlled substances and to the registration and control of regulated 
persons
176 and of regulated transactions
177”
178.  Section 822 of the CSA requires 
registration of every person who manufactures or distributes or intends to manufacture or 
distribute any controlled substance as well as persons who dispense
179 or intend to 
dispense any controlled substance.  This registration will result in a unique number being 
assigned to each registered person which must be made available to all suppliers by the 
customers at the time of purchase in order to greatly decrease the number of unauthorized 
transactions
180.  This registration requirement essentially serves as the impetus for 
creating an entirely closed system of distribution for substances listed on one of the 
schedules and the additional requirements on the handlers of controlled substances 
further accomplishes this objective
181. 
  Under the relevant provisions, the Attorney general shall register prospective 
manufacturers of Schedule II substances based on the following factors: an ability to 
maintain effective controls in preventing diversion of controlled substances, compliance 
will all applicable laws, promotion of advances in manufacturing these substances, prior 
                                                 
176 The term ''regulated person'' means a person who manufactures, distributes, imports, or exports a listed 
chemical, tableting machine, or an encapsulating machine or who acts as a broker or trader for an 
international transaction involving a listed chemical, a tableting machine, or an encapsulating machine.  21 
U.S.C. 802(38). 
177 The term ''regulated transaction'' means a distribution, receipt, sale, importation, or exportation of, or an 
international transaction involving shipment of, a listed chemical, or if the Attorney General establishes a 
threshold amount for a specific listed chemical, a threshold amount, including a cumulative threshold 
amount for multiple transactions (as determined by the Attorney General, in consultation with the chemical 
industry and taking into consideration the quantities normally used for lawful purposes), of a listed 
chemical, subject to some exceptions, or a distribution, importation, or exportation of a tableting machine 
or encapsulating machine.  21 U.S.C. 802(39). 
178 21 U.S.C. 821. 
179 The term ''dispense'' means to deliver a controlled substance to an ultimate user or research subject by, 
or pursuant to the lawful order of, a practitioner, including the prescribing and administering of a controlled 
substance and the packaging, labeling or compounding necessary to prepare the substance for such delivery.  
21 U.S.C. 802(10). 
180 Chapter 1 Controlled Substances Act, Drugs of Abuse.  Drug Enforcement Agency; 2005, 5. 
181 Id.  
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conviction records with respect to handling such substances, past experience in the 
manufacture of such substances, as well any other relevant factors having to do with 
public health and safety
182.   Hopeful distributors of Schedule II substances are issued 
registration based on similar criteria
183.  
  The CSA also required that all handlers keep and make available complete and 
accurate records of inventory
184 for a period of at least two years
185.  This recordkeeping 
requirement is essential to maintaining the closed network of distribution as it makes it 
possible to trace the flow of any controlled substance at each step and this alone, which 
will serve to prevent diversion of any of these substances help large corporations discover 
employees who are illegally diverting some of these substances to other outlets.
186  The 
CSA further stated that with respect to the records that must be kept of all transactions, it 
would be unlawful for any persons to distribute a Schedule II substance unless such 
distribution was effected pursuant to the receipt of an official written order on forms to be 
issued by the Attorney General
187.  These forms are preprinted with the customer 
information and the controlled substances may only be sent to the name and address on 
the form, as this process serves to reinforce Section 823’s registration requirement goals 
of keeping these substances out of the hands of unauthorized parties
188.  This form 
requirement also assists in monitoring as one copy of the form is forwarded by the 
supplier to a Drug Enforcement Agency office after a transaction is completed
189. 
                                                 
182 21 U.S.C. 823(a). 
183 21 U.S.C. 823(b). 
184 21 U.S.C. 827(a). 
185 21 U.S.C. 827(b). 
186 Chapter CSA supra  note 180 at 6. 
187 21 U.S.C. 828(a). 
188 Chapter CSA supra  note 180 at 6. 
189 Id.  
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  The CSA also placed restrictions on practitioners with regard to the dispensing of 
Schedule II substances that have classified as prescription drugs by the FDA, such as 
methamphetamine.  Unless the controlled substance in question is dispensed directly to a 
patient by a practitioner (other than a pharmacist), all other dispersals must be 
accompanied by a written prescription, save for emergency situations, and due to the 
potential risk for abuse and dependency, prescriptions for Schedule II substances may not 
be refilled
190.   
  The CSA proceeded to establish production quantity quotas for all controlled 
substances by giving the Attorney General the power to determine the production limits 
for a calendar year
191 based on sales and inventories information and drug usage 
estimates from the FDA
192.  Section 826 further stated provisions for establishing and 
revising individual production quotas, manufacturing quotas, and applications for quota 
increases by registrants
193. 
  Finally, the CSA provided for penalties for the unlawful manufacturing, 
dispensing, and distribution of controlled substances with the penalties usually being 
determined by schedule classification
194.  Over the years, the CSA has been amended 
many times and these penalties have changed along with the various provisions of the 
CSA over time
195.  A look at structure of the Controlled Substances Act reveals that there 
are a reasonable amount of controls in place to regulate the manufacture and distribution 
of methamphetamine, but the process of regulation is still one that is constantly evolving.  
                                                 
190 21 U.S.C. 829(a). 
191 21 U.S.C. 826(a). 
192 Chapter CSA supra note 180 at 8. 
193 21 U.S.C. 826. 
194 21 U.S.C. 841-864. 
195 Chapter CSA supra  note 180 at 8.  
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Much legislation has been passed over the years in efforts to amend the CSA so that it 
can better serve its goals and adapt to the changing environment, and much of the 
additional legislation has been in specific response to the methamphetamine problem.  
While the CSA of 1970 serves as the foundation for methamphetamine regulation, much 
of the CSA’s bite in the war against meth came in the form of amendments to the CSA in 
later federal legislation. 
Chemical Diversion and Trafficking Act of 1988 
  One of the problems in regulating a drug like methamphetamine, which is a 
purely synthetic drug that is a product of chemical precursors, was that there were no 
controls in place for regulating the basic ingredients that were used to synthesize and 
actually produce these drugs.  Until the Chemical Diversion and Trafficking Act of 
1988
196 was passed, there were virtually no obstacles in place for producers in obtaining 
the requisite chemical precursors
197 because there were no recordkeeping or inspection 
requirements on these precursors, nor were there any criminal penalties for diversion of 
the chemicals
198.  The Chemical Diversion and Trafficking Act of 1988 was one of the 
first attempts at chemical control by the DEA as it began regulation of 8 essential 
chemicals, 12 precursors
199, and related machinery
200 by imposing recordkeeping 
requirements on transactions involving these regulated chemicals
201.   
                                                 
196 Pub. L. 100-690, 102 Stat 4181. 
197 Chemical precursors are compounds that are required in the synthetic or extraction processes of drug 
production, and become incorporated into the drug molecule.   
198 U.S. Drug Enforcement Agency, Department of Justice.  Diversion Control, Inside the DEA, DEA 
Programs.  Available at http://www.usdoj.gov/dea/programs/diversion.htm. 
199 Chapter CSA supra  note 180 at 13. 
200 21 U.S.C. 843(a)(6) &(7). 
201 21 U.S.C. 830(a).  
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Notification was also now required at least 15 days in advance for those expecting 
to either import or export a chemical that was listed under the CSA
202.  It also lowered the 
quantity necessary to qualify as a substantial quantity of methamphetamine in illicit 
trafficking that would then trigger mandatory minimum sentences
203.  This legislation 
seemed to have had a noticeable impact on clandestine methamphetamine production 
because according to the DEA, both lab seizures and injuries attributable to illicit 
production dropped approximately 60% as the regulation imposed on bulk purchases of 
ephedrine and pseudoephedrine (both chemical precursors to methamphetamine) forced 
traffickers to search for alternative sources
204.  The traffickers soon realized, however, 
that an exemption existed for over the counter (OTC) products containing the chemicals, 
and it wasn’t long before they began to take full advantage of this loophole by relying on 
single entity ephedrine
205 tablets that were sold over the counter to supply the precursor 
they needed to continue with their production
206.  
Domestic Chemical Diversion and Control Act of 1993 
  Just as the methamphetamine traffickers had adjusted to the new regulation of 
precursor chemicals by finding a loophole in the CSA, Congress eventually adjusted as 
well, and responded with the amendments made to the CSA in 1993.  The Domestic 
Chemical Diversion and Control Act of 1993
207 extinguished the “precursor” and 
“essential” chemical distinction and instead re-classified the regulated chemicals as either 
                                                 
202 21 U.S.C. 971. 
203 21 U.S.C. 841(b)(1)(viii). 
204 Chapter CSA supra  note 180 at 14. 
205 Ephedrine is a chemical precursor of methamphetamine. 
206 Chapter CSA supra  note 180 at 14. 
207 Pub. L. 103-200, 107 Stat 2333.  
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List I
208 or List II
209, while simultaneously removing the exemption for OTC single entity 
ephedrine products, thus addressing the loophole that was the result of the CDTA
210.  
Also, by enacting section 814 of the CSA, it gave the Attorney General the authority to 
remove regulated transaction exemptions under 21 U.S.C. 802(39)(A)(iv) if they were 
found to be the object of diversion for use in illicit production of chemical substances
211. 
  Additional sections of the CSA (registration requirements) were amended to 
require all importers, exporters
212, manufacturers, and distributors of List I chemicals
213 
to go through the registration process and subsection (h) was added to Section 823 to set 
up guidelines for the Attorney General to follow when making a registration 
determination with respect to potential List I chemical distributors
214.  The DCDCA 
further required bulk manufacturers of List I chemicals to report total quantities produced 
annually and both record keeping and reporting requirements
215 were implemented for 
single entity ephedrine product transactions
216.  While these amendments seemed like a 
great improvement at the time, the traffickers adjusted by switching yet again to more 
readily available methamphetamine precursors such as single entity pseudoephedrine
217 
products and combination ephedrine
218 products
219, which were not regulated.           
                                                 
208 The term ''list I chemical'' means a chemical specified by regulation of the Attorney General as a 
chemical that is used in manufacturing a controlled substance in violation of this subchapter and is 
important to the manufacture of the controlled substances.  21 U.S.C. 802(34). 
209 The term ''list II chemical'' means a chemical (other than a list I chemical) specified by regulation of the 
Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this 
subchapter.  21 U.S.C. 802(35). 
210 Chapter CSA supra  note 180 at 14. 
211 21 U.S.C. 814. 
212 21 U.S.C. 957. 
213 21 U.S.C. 822. 
214 21 U.S.C. 823(h). 
215 21 U.S.C. 830. 
216 Chapter CSA supra  note 180 at 14. 
217 Pseudoephedrine is a chemical precursor to methamphetamine. 
218 Combination ephedrine products are drug products that contain main active ingredients in addition to 
ephedrine.  
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Comprehensive Methamphetamine Control Act 
  On October 3, 1996, President Bill Clinton signed the Comprehensive 
Methamphetamine Control Act of 1996
220 into law
221, and a few days later, he spoke of 
the necessity of the new legislation to combat the meth problem before it became too 
widespread: 
“Finally, I'm pleased that Congress has passed important antidrug 
legislation that I submitted last spring to deal with methamphetamine. 
Methamphetamine is a deadly drug that unfortunately is gaining 
popularity. In 2 years, deaths from this drug have doubled. Currently 
isolated in geographic pockets, its use now threatens to spread nationwide. 
With this legislation we increase penalties for trafficking in meth, toughen 
the penalties for trafficking in those chemicals used to produce meth, and 
give the Justice Department authority to regulate and seize those 
chemicals. I am particularly pleased that we are acting before this 
epidemic spreads.”
222 
   
  While President Clinton spoke of the need to act before the epidemic spreads, it 
seems like Congress had a better idea of just how big a threat was posed by 
methamphetamine within our borders as they found the following: 
''(1) Methamphetamine is a very dangerous and harmful drug. It is highly 
addictive and is associated with permanent brain damage in long-term 
users. 
''(2) The abuse of methamphetamine has increased dramatically since 
1990. This increased use has led to devastating effects on individuals and 
the community, including – 
''(A) a dramatic increase in deaths associated with 
methamphetamine ingestion; 
                                                                                                                                                
219 Chapter CSA supra  note 180 at 14. 
220 Pub. L. 104-237, 110 Stat 3099. 
221 Methamphetamine and the Law: A Legal History of Crank.  Available at 
http://www.montana.edu/wwwai/imsd/rezmeth/legal.htm. 
222 Remarks on the signing of the Comprehensive Methamphetamine Control Act of 1996 – Pres. Bill 
Clinton – Transcript, Weekly Compilation of Presidential Documents; October 7, 1996.  Available at 
http://findarticles.com/p/articles/mi_m2889/is_n40_v32/ai_18920461/pg_3.   
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''(B) an increase in the number of violent crimes associated with 
methamphetamine ingestion; and 
''(C) an increase in criminal activity associated with the illegal 
importation of methamphetamine and precursor compounds to 
support the growing appetite for this drug in the United States. 
''(3) Illegal methamphetamine manufacture and abuse presents an 
imminent public health threat that warrants aggressive law enforcement 
action, increased research on methamphetamine and other substance 
abuse, increased coordinated efforts to prevent methamphetamine abuse, 
and increased monitoring of the public health threat methamphetamine 
presents to the communities of the United States.''
223 
 
The Comprehensive Methamphetamine Control Act was a step in the right 
direction, but it still left much to be desired in terms of its overall impact on the 
methamphetamine problem.  On its face, it seemed to implement a number of new 
restrictions on both methamphetamine and its precursor chemicals, but it still exhibited 
some glaring weaknesses which left yet another loophole for traffickers to take advantage 
of. 
  The CMCA made a number of notable changes to the CSA by expanding its reach 
and attempting to enforce stiffer penalties in response to the growing methamphetamine 
problem.  It made it unlawful for traffickers to manufacture or distribute listed chemicals 
with the intent to unlawfully import or with knowledge that they will be unlawfully 
imported into the U.S.
224 and it stiffened the penalties for those who violated the 
aforementioned section by importing in List I chemicals
225.  Other related penalties were 
stiffened all across the board as well, as potential prison sentences were raised from 10 
years to up to 20 years for those who either possess listed chemicals with the intent to 
                                                 
223 21 U.S.C. 801 Note. 
224 21 U.S.C. 959(a)(1) & (2). 
225 21 U.S.C. 960.  
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manufacture or possess and distribute with knowledge that others intend to manufacture 
controlled substances
226.   
Section 842 of the CSA was amended to make it unlawful for a person to 
distribute a laboratory supply to a person who uses or attempts to use the supply to 
manufacture a controlled substance, with reckless disregard for the uses to be made of the 
supply
227.  Such unlawful behavior was punishable by a civil fine of up to $250,000
228.  
The CMCA amended Section 843 to allow the DEA to pursue and injunction against 
prospective violators of the section or Section 842
229, and it added a new penalty of not 
more than 10 years and/or a fine of up to $30,000 for any persons who possess or 
distribute supplies with the intent to manufacture or facilitate the manufacture of 
methamphetamine
230.   
The CMCA further barred the possession of a listed chemical by a person who 
had obtained the chemicals pursuant to valid registration if the registration was suspended, 
expired, revoked, or no longer used to conduct business in the manner originally 
contemplated
231.  Iodine and hydrochloric acid, two ingredients often used in the meth 
production process, were added to the CSA as List II chemicals
232 and mail order 
purchases of products containing pseudoephedrine, phenylpropalonamine
233, and 
ephedrine were also restricted
234.  It also created a restitution provision for cleanup of 
clandestine laboratory sites that were found to have been manufacturing 
                                                 
226 21 U.S.C. 841(c)(3). 
227 21 U.S.C. 842(a)(11). 
228 21 U.S.C. 842(c)(2)(C). 
229 21 U.S.C. 843(f). 
230 21 U.S.C. 843(d)(2). 
231 21 U.S.C. 844 (a)(1). 
232 21 U.S.C. 802(35)(I) & (J). 
233 Phenylpropanolamine is a chemical precursor to methamphetamine. 
234 21 U.S.C. 830(b)(3).  
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methamphetamine by enabling the Attorney General to order defendants convicted of 
such a violation to pay for the cleanup costs incurred by the federal government, in 
addition to paying restitution to any individuals who may have been harmed as a result of 
the offense
235.      
The new legislation created an advisory panel of representatives from various 
agencies and law enforcement to convene under the Attorney General in order to create 
educational programs for distributors of products that contain chemical precursors and it 
also mandated that the Attorney General would continue its current efforts to provide 
seminars and training for distributors and to provide assistance to local law enforcement 
in facilitating such educational programs
236.  A Methamphetamine Interagency Task 
Force was also established for the first time which would “be responsible for designing, 
implementing, and evaluating the education and prevention and treatment practices and 
strategies of the Federal Government with respect to methamphetamine”
237, and a public 
health monitoring system to collect and disseminate information regarding 
methamphetamine was also established
238.         
One of the most important changes that the CMCA made to the CSA in response 
to the traffickers’ switch to pseudoephedrine and combination ephedrine products was to 
amend the definition of a regulated transaction in order to remove the exemption that was 
in place for products that contained pseudoephedrine, phenylpropanolamine, and 
ephedrine
239.  A new 24 gram base sale threshold designation in single transactions was 
made with respect to determining whether or not distributors of pseudoephedrine and 
                                                 
235 21 U.S.C. 853(q). 
236 21 U.S.C. 872a. 
237 21 U.S.C. 801 Note. 
238 42 U.S.C. 290aa-4 Note. 
239 21 U.S.C. 802(39)(A)(iv)(I)(aa).  
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phenylpropanolamine products would be required to report to the Attorney General
240 as 
mandated by the CSA
241, but unfortunately, the definition of regulated transaction was 
further amended to exempt sale of ordinary OTC pseudoephedrine and 
phenylpropanoamine products
242.  This exemption of OTC products containing the 
methamphetamine chemical precursors provided the traffickers with yet another loophole 
and lessened the potential impact of the legislation. 
The term "ordinary over-the-counter pseudoephedrine or phenylpropanolamine 
product" is defined to mean any products containing the precursors sold in package sizes 
of not more than 3.0 grams of either base that is packaged in blister packs with each 
blister containing two or less dosages and for liquids, it refers to any package sizes that 
contain less than 3.0 grams of either base
243.  By defining over the counter purchases as 
such, these provisions meant that any retail sales that fell into this definition would be 
unregulated, thus leaving traffickers a reliable, albeit a bit more cumbersome method of 
obtaining the necessary precursors.   
Furthermore, the CMCA went on to define combination ephedrine product and 
established a similar 24 gram base sale threshold for retail distributors without regard for 
its packaging, and a 1 kilogram base threshold for other distributors and importers
244.  It 
further softened its purported hard line against these chemical precursors when it 
amended the CSA to expand the opportunity for reinstatement of these precursor 
chemicals as list chemical exemptions, contingent on certain criteria being met
245, and by 
                                                 
240 21 U.S.C. 802 Note. 
241 21 U.S.C. 830(b)(3). 
242 21 U.S.C. 802(39)(A)(iv)(I)(aa). 
243 21 U.S.C. 802(45). 
244 21 U.S.C. 802 Note. 
245 21 U.S.C. 814(e).  
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shortening the required record retention period from 4 years to 2 years for List I 
chemicals
246.  Although the changes brought on by the Comprehensive 
Methamphetamine Control Act were steps in the right direction, the “blister pack 
exemption” that resulted from the decision not to regulate ordinary OTC transactions 
ensured that it would not be enough to prevent methamphetamine traffickers from 
continuing their illicit production and distribution. 
The Methamphetamine Anti-Proliferation Act of 2000 
  The Methamphetamine Anti-Proliferation Act of 2000 was the next step taken by 
Congress in reaction to the continuing rise of methamphetamine use in the United 
States
247.  The new legislation made the restitution provision, first introduced in the 
CMCA, mandatory as against lab operators
248 and it finally made it unlawful to sell or 
offer for sale drug paraphernalia that was related to methamphetamine use
249.  The 
legislation also allowed for funding from the DOJ Assets Forfeiture Fund to be put 
towards hazardous waste cleanup at illegal meth sites
250 as well as allowing for the 
disbursement of grants to State and local officials for cleanup of such sites
251.   
It further mandated that the DEA shall carry out training programs for law 
enforcement and localities deemed to have significant levels of meth-related crimes by 
teaching them to better deal with clandestine lab sites
252 and it ordered the Director of 
National Drug Control Policy to focus the appropriation of funds for supplying additional 
law enforcement personnel to areas designated by the Director to be high intensity 
                                                 
246 21 U.S.C. 830(a)(1). 
247 Pub. L. 106-310, 114 Stat 1101. 
248 21 U.S.C. 853(q). 
249 21 U.S.C. 863. 
250 28 U.S.C. 524(c)(1)(E)(ii)(I). 
251 42 U.S.C. 3571. 
252 21 U.S.C. 872 Note.  
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methamphetamine trafficking
253.  The MAPA also allowed for expansion on research of 
methamphetamine by allowing the Director of the National Institute on Drug Abuse to 
issue grants for research relating to methamphetamine abuse,
254 and granted the Director 
of the Center for Substance Abuse treatment to make grants to States with high rising 
methamphetamine rates so that they could expand their treatment efforts for 
methamphetamine users
255.  The Public Health Service Act was also amended to provide 
funding for both school-based and community-based outreach and prevention programs 
concerning the dangers of methamphetamine abuse
256. 
The most notable change brought upon by MAPA focused on more stringent 
regulation of the chemical precursors as the previous 24 gram threshold for reporting 
sales of pseudoephedrine and phenylpropanolamine products was reduced to 9 grams in 
single transactions and transactions involving packages containing more than 3 grams of 
base pseudoephedrine and phenylpropanolamine were now also regulated
257.  The House 
Committee hearing stated that the DEA had expressed great concern about the diversion 
of 100-count bottles of ephedrine and pseudoephedrine tablets to home labs and that from 
a practical standpoint, this would lower reporting and registration thresholds for 
distributors to approximately three such bottles from the previously allowed eight
258.  By 
lowering the threshold that triggered reporting requirements, the DEA was obviously 
attempting to bring more transactions into its purview.  MAPA also made it unlawful to 
                                                 
253 21 U.S.C. 1706. 
254 42 U.S.C. 285o-2. 
255 42 U.S.C. 290bb-9. 
256 42 U.S.C. 290bb-21. 
257 21 U.S.C. 802(39)(a)(iv)(II). 
258 H.R. Rep. No. 106-878 Part I (2000).  
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steal or transport stolen anhydrous ammonia
259 across State lines with the intent to use or 
knowledge of intent to use the ammonia for manufacture of controlled substances
260.  
Finally, MAPA also called for increased federal sentencing for violations involving 
ephedrine, pseudoephedrine, and phenylpropanolamine
261.  Although MAPA did make 
some noticeable improvements to the existing legislation, it wasn’t until the Combat 
Methamphetamine Epidemic Act was passed in 2006 that real strides and progress were 
made in the attempt to slow down meth production. 
Combat Methamphetamine Epidemic Act of 2005 
  The Combat Methamphetamine Epidemic Act of 2005 was passed as part of the 
USA Patriot Improvement and Reauthorization Act of 2005 on March 9, 2006
262.  The 
Combat Methamphetamine Epidemic Act amends the CSA in a number of ways.  It 
finally added ephedrine, pseudoephedrine, and phenylpropanolamine products to the list 
of listed chemicals
263 and also redefined “retail distributor” to now include entities who 
distributed ephedrine products, in addition to the previously listed pseudoephedrine and 
phenylpropanolamine products to walk-in or face-to-face customers for personal use
264.  
There was a push at the time the legislation was passed for pseudoephedrine and other 
meth precursor chemicals to be designated as Schedule V controlled substances, but this 
classification was ultimately rejected as it would have eliminated the ability of consumers 
                                                 
259 A chemical used in the methamphetamine cooking process, as mentioned above in the Cooking 
Methamphetamine section. 
260 21 U.S.C. 864. 
261 28 U.S.C. 994. 
262 Pub. L. 109-177, 120 Stat 192. 
263 These three precursors were defined as “scheduled listed chemical products”.  21 U.S.C. 802(45)(A)(i). 
264 21 U.S.C. 802(49).  
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to lawfully obtain otherwise safe medicines containing such chemicals without visiting a 
pharmacy
265. 
  It also made significant restrictions involving the sales quantity, placement of the 
products, logbook record requirements, and training of sales personnel
266.  With respect 
to chemical products containing ephedrine, pseudoephedrine, or phenylpropanolamine 
bases, sales were not to exceed a daily amount of 3.6 grams of base for any purchaser, 
regardless of the actual number of transactions, up to a total of 9 grams within a 30 day 
period,
267 and sellers and distributors were not to sell such regulated products in 
nonliquid form unless they were packaged in blister packs with each blister containing 
two or less dosages
268. 
  Retailers were to place all such products in a location where the consumer would 
not be able to access the merchandise before sale (“behind-the-counter” rule), which was 
made to include locked cabinets that were in areas of the facility to which consumers did 
have direct access
269.  Under the CMEA, sellers were then required to deliver the product 
directly to the customer
270, and then to maintain a list of all such transactions that 
included the following information: name of the product, quantities sold of the product, 
names and addresses of the purchasers, and dates and times of sales (the “logbook” 
requirement)
271.  An exemption to the logbook requirement was made for sales made to 
                                                 
265 H.R. 109-299 Part I (2005). 
266 21 U.S.C. 830. 
267 21 U.S.C. 830(d)(1). 
268 21 U.S.C. 830(d)(2). 
269 21 U.S.C. 830(e)(1)(A)(i). 
270 21 U.S.C. 830(e)(1)(A)(ii). 
271 21 U.S.C. 830(e)(1)(A)(iii).  
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an individual of a single sales package if that package contained less than 60 milligrams 
of pseudoephedrine
272. 
  For transactions that required a logbook entry, purchasers were now required to 
present a State or federal government issued photo I.D. to the seller
273 and to both sign 
the logbook and fill in his or her name, address, and date and time of purchase
274, while 
the sellers were required to determine that the information entered in the logbook was 
accurate,
275 in addition to entering the information regarding the name of the product and 
the quantity sold into the logbook
276.  All logbooks were to include a warning to potential 
customers that entering false information in the logbooks could subject them to criminal 
penalties
277.  The sellers were expected to maintain all the entries from the logbook for a 
minimum of two years from each entry
278 and all individuals who were actually 
responsible for delivering the product into the hands of the customer were expected to 
submit self-certifications to the Attorney General stating that they had undergone the 
training required to effect such transactions,
279 copies of which were to be maintained by 
the seller on the premises
280.   The self-certification process and program, which required 
a separate certification for each place of business that sold scheduled listed chemical 
products,
281 was established by the Attorney General,
282 and such certification would be 
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held invalid unless it included a statement that the seller understood each of the 
requirements
283.   
The CMEA also placed a set of restrictions on mobile retail vendors
284 requiring 
them to not only place the regulated products in a locked cabinet
285 but also barring them 
from selling more than 7.5 grams base of the restricted chemical products to a customer 
within a 30 day period
286.  Entities engaged in mail-order sales were similarly required to 
verify the identities of the purchasers
287 according to guidelines established by the 
Attorney General and were also limited to selling not more than 7.5 grams of the 
scheduled listed chemical products to a single customer within a 30 day period
288.  A 
possible exemption from these new requirements was established for scheduled listed 
chemical products that the Attorney General determined could not be used in the illicit 
manufacture of methamphetamine
289. 
The CMEA amended the penalties for simple possession of controlled substances 
by making it unlawful for any person to purchase more than 9 base grams of a scheduled 
listed chemical product within a 30 day window, except that, of those 9 grams, not more 
than 7.5 grams were to be imported by the purchaser
290.  It also gave the Attorney 
General the power to prohibit knowing or reckless violators of the new reporting 
requirements from selling any scheduled listed chemical products, with any subsequent 
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sales violating this prohibition resulting in the same penalties applicable for the initial 
violations
291. 
The CMEA then amended the CSA to allow the Attorney General to finally 
regulate the production of ephedrine, pseudoephedrine, and phenylpropanolamine by 
establishing quotas, as had been previously in effect for controlled substances on one of 
the five schedules
292, and it accordingly made it unlawful for any person to manufacture 
such scheduled listed chemical products in a manner that conflicts with his registration
293 
or in excess of his allotted production quota
294.  Importation of these chemical precursors 
into the U.S. was also banned
295 except in amounts necessary for medical, scientific, or 
other legitimate purposes as determined by the Attorney General,
296 but the CMEA did 
add a provision outlining the process for requesting an increase in the import quota for 
authorized importers
297.  Importers were further subject to increased regulations that 
required importers to wait for a minimum of 15 days after giving notice regarding the 
intended transaction to the Attorney General, before transferring any imported listed 
chemicals to a party who was not a regular customer,
298 and any subsequent changes with 
respect to either the quantity of the chemical being transferred or the identity of the 
transferee would have to be reported to the Attorney General, thus starting another 15 day 
wait period
299.  The Attorney General was given the power to suspend the 
aforementioned transactions if it believed that the chemicals were in danger of being 
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diverted to clandestine drug manufacturing operations
300  and all importers were required 
to send the Attorney General return declarations outlining all the details of the transaction 
within 30 days
301. 
The CMEA came at a time when the previous federal legislation had made a 
considerable impact on restricting the availability of the necessary ingredients to 
manufacture methamphetamine and as a result, many of the U.S. producers were forced 
to look elsewhere for their supplies of precursor chemicals and distributors were forced to 
look outside of the U.S. for their methamphetamine supplies.  It should come as little 
surprise that the CMEA attempted to tackle this issue by focusing on importation of 
regulated chemicals into the U.S. and smuggling of methamphetamine products across 
U.S. borders.  The CMEA amended the CSA to require all importers to include all 
relevant information regarding the foreign chain of distribution from the manufacturer to 
the importer in its required notice to the Attorney General,
302 and authorized the Attorney 
General to request further information regarding the distribution process of the product 
from any of the named distributors in the foreign chain of distribution
303.   
It amended the Foreign Assistance Act of 1961
304 to call for identification of the 
world’s five largest exporting countries of pseudoephedrine, ephedrine, and 
phenylpropanolamine
305 in order to compare it legitimate demand for these chemicals 
worldwide
306.  It also mandated identification of the five countries with the highest rate of 
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importation and diversion of these chemicals,
307 to be determined by both the difference 
in actual importation of these chemicals versus legitimate demand
308 and the best 
available data regarding diversion of these chemicals for illicit methamphetamine 
production in these countries
309.  Under the Foreign Assistance Act, these countries 
would jeopardize receipt of previously allocated monetary assistance from the U.S.
310 
unless they were to receive certification from the President of the United States that they 
had either fully cooperated with the United States in the previous year
311 or that our 
nation’s vital interests outweighed the need to withhold aid to these countries
312.  For 
countries that the President failed to certify under the aforementioned process, the 
Secretary of State, in tandem with the Attorney General, was to submit to Congress a 
comprehensive plan to prevent diversion of these chemicals in these countries, and 
$1,000,000 of funding was appropriated for this purpose for the years 2006 and 2007
313. 
As for the growing problem of methamphetamine being smuggled into the United 
States, the CMEA mandated that the Secretary of State was to take necessary actions in 
order to prevent smuggling of methamphetamine across U.S. borders from Mexico
314 by 
improving bilateral efforts at the border,
315 working with Mexican authorities to improve 
their ability to fight illicit production and distribution,
316 and encouraging the Mexican 
government to fight the diversion of pseudoephedrine to meth production operations
317.  
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$4,000,000 of funding was appropriated to the Secretary of the State so that he may carry 
out this mandate
318.  Criminal penalties were also increased by an additional consecutive 
imprisonment term of up to 15 years
319 for those caught smuggling methamphetamine by 
utilizing a facilitated entry program into the U.S., such as a dedicated commuter lane or 
accelerated inspection system,
320 and any violators were to be permanently barred from 
ever being eligible to use any facilitated entry program in the future
321.  Penalties were 
also stiffened for those attempting to distribute methamphetamine on premises where a 
minor was present or living as they would receive an additional prison term of up to 20 
years or a fine or both
322. 
In an effort to gather more information on this growing epidemic, the Attorney 
General was now required on a semiannual basis to submit to Congress
323 information 
related to DEA allocation of resources to prosecute methamphetamine violations
324 and 
the steps taken to determine priority of allocation
325 for violations involving importation 
of meth
326, manufacture of meth
327, or endangerment to children
328.  The Solid Waste 
Disposal Act was also amended by the CEA to require a report at least once every 24 
months indentifying byproducts from the methamphetamine production process and 
whether such byproducts should be designated as hazardous waste
329. 
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Finally, the CMEA appropriated funding for various programs to assist local and 
State officials in confronting the spread of methamphetamine use in their communities.  
$99,000,000 was appropriated to programs
330 designed to investigate and prosecute 
violations of methamphetamine-related laws
331, reimburse DEA for cleanup costs of 
production sites
332, support local environmental and health agencies
333, and procure 
necessary resources that would result in a reduction of such violations
334.  Grants were 
also authorized for services coordinating assistance to children who reside in homes 
where illicit meth production is taking place
335 with $20,000,000 of funding being made 
available for such services
336.  Lastly, funding was also appropriated to programs that 
focused on collaborations between the child welfare, criminal justice, and substance 
abuse systems to address the problems faced by both pregnant and parenting women 
methamphetamine abusers
337.  While it was far from perfect, the Combat 
Methamphetamine Epidemic Act has been the most comprehensive and expansive federal 
methamphetamine legislation to date and it will hopefully have a positive impact in 
reversing the growth trends we have witnessed in the past. 
IS LEGISLATION WORKING? 
METHAMPHETAMINE PROGRESS 
   In a methamphetamine progress report conducted in 2006, it was reported that 
monthly methamphetamine laboratory incidents had topped out in March 2004 when 
reaching an all-time high of 2,094 and has been on a steady decline, with a drop of more 
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than 30% annually by 2005
338.  There were only 3,160 laboratory incidents reported in 
the first four months of 2006 at the time the numbers were reported, which represented a 
51.1% decline from 2005 and a 56.1% decline from 2004
339.  Workplace drug testing 
violations also showed a 12.4% decline in the first five months of 2006 compared to the 
same time period in 2005
340.  The decrease in illicit meth lab incidents seems to inspire 
some confidence that the legislation preventing access to precursor chemicals has had a 
positive impact on cutting down on meth production within the country, but the question 
of whether the overall supply and availability of methamphetamine is decreasing remains 
unresolved. 
  The National Methamphetamine Threat Assessment which was released by the 
National Drug Intelligence Center in December of 2007 reveals some unsettling 
information
341.  According to the report, while methamphetamine use has pretty much 
remained stable since 2002 after experiencing significant increases throughout the 1990’s 
and domestic production of the drug has decreased dramatically since 2004, the overall  
methamphetamine markets in the United States have remained unchanged
342.  This is 
likely due to the growth of methamphetamine distribution networks in Mexico, which 
despite increased import restrictions on precursor chemicals has still managed to become 
the number one supplier of methamphetamine to the U.S
343.  Methamphetamine 
production in Canada has seen noticeable spikes as well as biker gangs and Asian drug 
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trafficking organizations have ramped up their production in response to the declining 
production domestically in the U.S.
344   
  Moving forward, it seems as if these trends of foreign manufacture and 
exportation into the U.S. will continue as predictive estimates indicate that smuggling of 
ephedrine from Columbia into Mexico, in response to the crackdown by the Mexican 
government, will continue to rise as Mexico further restricts importation of these 
chemicals
345.  It also seems plausible that Columbia is ready to step right in and take 
Mexico’s place as the primary manufacturer and supplier of methamphetamine to the U.S. 
if a situation arose where Mexico was unable to continue to meet demand
346.  While the 
Canada-based drug trafficking organizations have yet to contribute a significant amount 
of methamphetamine to the U.S., they seem poised to fill any potential voids that may 
arise in affected markets as their production levels continue to rise
347.  After taking a 
closer look, it is evident that the federal legislation has been successful in decreasing the 
amount of domestic production by making it harder to obtain the necessary ingredients, 
but the fall in domestic production has simply been substituted by increasing importation 
of the drug
348.  In my opinion, given all the associated dangers and hazards associated 
with domestic production by the clandestine laboratories, this in and of itself is no small 
feat.  It does, however, beg the question of what else we can be done to better manage 
this outbreak. 
A MORE COMPREHENSIVE APPROACH IS NEEDED 
IS SUPPLY SIDE-RESTRICTION THE BEST APPROACH? 
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  The previous section showed that while increased legislation and regulation of 
methamphetamine and its essential ingredients did manage to decrease the domestic 
supply of the drug, it is unclear whether it has had much of an impact on the overall 
supply of the drug in the market.  I’ve always had the intuition that in situations where a 
combination of a strong demand for a product and high profit margins exists, there would 
always be an adequate supply of the product no matter how much effort was focused on 
regulating the source.  Methamphetamine seems to clearly fall into this category as it 
exhibits a relatively inelastic demand, due to the addictive nature of the drug, and it offers 
those involved in the trade the opportunity to make money hand over fist.  It seems like 
as soon as one supplier is taken out, two more suppliers are prepared to take his place. 
  The limits of supply-side restrictions in the war on drugs have been the issue of 
much debate in the past.  While the proponents of supply-side restriction approach point 
to the resulting decreases in drug violations as evidence of its efficacy, it has been posited 
that much of the benefit from supply-side restriction is the result of demand-side 
mechanisms: incarcerating the dealers who are supplying the drugs is an effective method 
of actually limiting demand since much of the distributors are heavy users of these same 
drugs
349.   
Looking at the past efforts by the U.S. to restrict supplies of cocaine and heroin 
has shown that for the most part, they have failed time and time again
350.  Not only have 
these strategies proven to be ineffective, but they have also been known to drive market 
forces that result in increased trafficking, to produce unexpected and unintended 
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consequences, and to ultimately make the problem worse rather than better
351.  Attempts 
to regulate legally produced methamphetamine resulted in the proliferation of clandestine 
production laboratories and evidence suggests that the crackdown on domestic producers 
may have led directly to their working with Mexican cartels to produce even more potent 
forms of the drug
352.  It is clear that efforts focused solely on curbing the supply of 
methamphetamine are inadequate and alternative avenues ought to be considered.  
Prevention and treatment measures should be increased in order to decrease the demand 
for the drug and harm reduction practices should be implemented in order to minimize 
the damage that results from its use. 
DEMAND-SIDE STRATEGIES 
TREATMENT 
  Effective treatment that helps users to deal with their addiction should have a 
considerable impact on the methamphetamine problem since it would noticeably lessen 
the demand for the drug.  The current literature and evidence indicate that those who 
abuse methamphetamine respond favorably to existing treatments and that both their 
response to treatment and rates of success compare similarly to treatments for other drug-
related problems
353.  That fact that methamphetamine treatment compares well with other 
drug treatments is relevant because of the abundance of evidence that suggests that 
increased funding for treatment programs for other drugs has been a very cost-effective 
method of reducing drug abuse
354.  Studies have shown that treatment can be 10 times 
more cost-effective than drug interdiction, 15 times more effective than increased 
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spending on domestic enforcement, 23 times more effective than attempting to eradicate 
the source, and can save taxpayers more than seven dollars for every dollar invested in 
such programs, due to savings resulting from decreases in related crime and healthcare 
burdens
355.  This data reinforces the notion that effective treatment must play a very 
integral role in the comprehensive plan to battle the spread of methamphetamine. 
PREVENTION 
  It is clear that strategies to fight the growing demand for methamphetamine must 
be employed on two fronts.  While treatment is successful in curbing demand among 
current users, a lot of our efforts must be focused on preventing the growth of new users 
as well.  It is essential to take steps early on to properly educate the nation’s youth about 
the potential pitfalls and dangers of methamphetamine use.  Funding for after-school 
programs must increase because research has shown that children who are involved in 
extra-curricular activities are far less likely to engage in substance abuse than their peers 
who don’t participate in such programs
356.  The funding that is currently spent on drug 
prevention programs such as D.A.R.E.
357 and the National Youth Anti-Drug Media 
Campaign ought to be diverted towards establishing more after-school programs because 
the scare-based tactics and “manipulative advertising” employed by these programs have 
proven to be largely ineffectual
358.  The drug education programs must be revamped in 
order to offer the children various avenues to obtain more facts and participate in 
interactive discussions, and the zero-tolerance policies for drug violations that are 
currently in place in most schools that call for automatic pensions or expulsions need to 
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be replaced instead with access to treatment programs for all offenders
359.  It has been 
encouraging to see efforts made in this department by legislation such as the increased 
funding for school-prevention programs that resulted from passage of the Meth Anti-
Proliferation Act
360.  The youth of this nation are a lot smarter than we give them credit 
for and employing scare tactics and attempting to manipulate their views on drugs 
through the media only serve to insult their intelligence and in extreme cases, may 
actually drive students towards drugs.  For prevention strategies to be effective, students 
really need access to better information and interesting after-school alternatives to keep 
them busy and away from drugs.  
DEMAND REDUCTION HAS ITS LIMITS 
  While both prevention and treatment seem like obvious solutions to attack the 
problem of demand, they are not without their limitations.  While there have been 
promising results from increased funding for drug education and after-school programs, 
nobody could claim to know the right formula for preventing most of the kids from 
engaging in drug abuse
361.  It is undoubtedly an ever-evolving process, and one that will 
take quite some time before we can figure out how to strike the proper balance between 
various prevention solutions.  While the case for treatment is somewhat stronger than 
prevention, this is tempered by the fact that is it not possible to treat patients who do not 
seek out treatment
362.  If the treatment programs were better integrated into the health 
care system, this might encourage addicts to pursue treatment
363.  The practice of entering 
more violators into drug treatment programs as opposed to putting them into prison 
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would also substantially increase the number of users who receive treatment.  Any 
measures that could be implemented to neutralize these inherent limitations in prevention 
and treatment efforts should be explored thoroughly.           
HARM REDUCTION  
  While taking steps to decrease the prevalence of meth abuse is crucial, it is just as 
important to implement harm reduction measures that will soften the negative impacts 
associated with methamphetamine abuse.  If one proceeds under the reasonable 
assumption that there will be some level of methamphetamine abuse regardless of the 
amount of resources expended, the next logical step is to minimize the harms that result 
from the activity.   Although harm reduction measures do not seem to be “tough” enough 
to adequately deal with the issue, they do have an intrinsic appeal as they serve to 
maximize societal welfare
364.  A host of strategies are available for harm reduction such 
as needle exchange programs, condom distributions, increased funding for lab site 
cleanups, and better training for law enforcement
365.  Implementing these programs in 
conjunction with a concerted effort to reduce overall use will best serve the objective of 
minimizing the harms associated with illicit methamphetamine manufacture, distribution, 
and use
366.     
CONCLUSION 
  The body of knowledge and data available to us has painted a clear picture of the 
methamphetamine epidemic.  Methamphetamine is a very dangerous drug with far 
reaching effects, not only to its users but to the community at large, and these effects pose 
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a very credible threat to this nation and its citizens.  While the federal government may 
have gotten off to a slow start, it has made great efforts as of late to give the “war on 
meth” the proper attention that it undoubtedly demands.  While this phrase has become 
somewhat of a buzzword as of late, I feel that it does not accurately depict the current 
state of affairs with respect to our nation’s methamphetamine problem.  
 I am reminded of a line I once heard that said something to the effect that the U.S. 
is not really waging a war on drugs because all wars eventually come to an end, while 
this particular “war” was unlikely to do so.  I tend to agree that our response to this 
problem is not best described as a war and characterizing it as such may actually be a 
disservice to the cause and hinder our progress.  Methamphetamine is not an opponent 
that can be struck down or defeated in the traditional sense, and calling it a war brings 
with it unrealistic hopes and expectations of “victory”.  It also serves to affect the policy 
choices we make as we attempt to give our “enemies” in this war a face (e.g. 
manufacturers, importers, etc.) and focus entirely too much of our efforts and resources 
on conquering them.  It is my sincere belief that methamphetamine is not so much an 
adversary that can be overcome but rather a chronic illness that we must accept and learn 
to manage.  The legislation to restrict methamphetamine precursors has made great 
progress in reducing the domestic supply of methamphetamine in the market but going 
forward, a much more comprehensive and multi-faceted strategy is necessary if any real 
strides are to be made in the efforts to treat the symptoms of our nation’s debilitating 
condition and to take the necessary steps towards recovery. 